As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Rejuvenating cells to reverse age-related diseases. Life Biosciences is a biotechnology company pioneering cellular rejuvenation using epigenetic restoration to reverse diseases of aging.
News
Life Biosciences Appoints Stephen Webster to Board of Directors
Former Spark Therapeutics Chief Financial Officer brings deep biotech finance, commercialization, and governance expertise BOSTON, August 10, 2026 - Life Biosciences ("Life Bio"), a clinical-stage biotechnology company pioneering cellular rejuvenation med
Read more
Report
Longevity medicines do-or-die moment
July 24, 2026 ER-100 Enters Optic Neuropathy Trial The Ophthalmologist
Read more
Report
BBC Audio Rethink Rethink... how we age
How scientists can now make old damaged cells young again.
Read more
Report
Re-Setting the Epigenetic Clock To Reverse Cellular Aging
July 24, 2026 ER-100 Enters Optic Neuropathy Trial The Ophthalmologist
Read more
Report
ER-100 Enters Optic Neuropathy Trial
Life Biosciences doses first patient in epigenetic restoration clinical trial
Read more
Report
Pro access
Upgrade to see all 30 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
